We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Kedem Pharmaceuticals Introduces Their Sublingual Drug Delivery System

Product News   Feb 08, 2012

 
Kedem Pharmaceuticals Introduces Their Sublingual Drug Delivery System
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Enterprise Therapeutics’ First Potentiator Program for Treatment of Respiratory Diseases Acquired by Roche

Product News

Enterprise Therapeutics Ltd (Enterprise), today announced its novel TMEM16A potentiator portfolio has been fully acquired by Roche and will be developed by Genentech. The portfolio includes ETD002 which recently entered Phase 1 trials.

READ MORE

New Collaboration Explores Efficacy of Gene Delivery Vector Tech in Diabetes and Multiple Sclerosis

Product News

Amarna Therapeutics has announced today that it has entered into a collaboration with scientists from the Progreso y Salud Foundation (FPS) at Cabimer in Seville, to jointly examine the efficacy of Amarna’s SVec™ gene delivery vector for the development of effective immunotherapies for diabetes mellitus type 1 (DM1) and multiple sclerosis (MS).

READ MORE

Univercells Technologies introduces the NevoLine™ Upstream Platform

Product News

This upstream manufacturing platform is suitable for multiple viral applications to support the booming gene therapy market and offer a cost-effective tool for rapid response to emerging infectious diseases.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE